Geode Capital Management’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,504
| Closed | -$13.1K | – | 4808 |
|
|
2023
Q3 | $13.1K | Buy |
+10,504
| New | +$12.7K | ﹤0.01% | 4690 |
|
|
2023
Q2 | – | Sell |
-4,470
| Closed | -$45.6K | – | 4841 |
|
|
2023
Q1 | $45.6K | Sell |
4,470
-113
| -2% | -$1.63K | ﹤0.01% | 4542 |
|
|
2022
Q4 | $72K | Sell |
4,583
-13
| -0.3% | -$287 | ﹤0.01% | 4501 |
|
|
2022
Q3 | $127K | Hold |
4,596
| – | – | ﹤0.01% | 4450 |
|
|
2022
Q2 | $129K | Buy |
4,596
+238
| +5% | +$10.8K | ﹤0.01% | 4483 |
|
|
2022
Q1 | $303K | Hold |
4,358
| – | – | ﹤0.01% | 4181 |
|
|
2021
Q4 | $473K | Hold |
4,358
| – | – | ﹤0.01% | 4081 |
|
|
2021
Q3 | $524K | Sell |
4,358
-137
| -3% | -$16K | ﹤0.01% | 4012 |
|
|
2021
Q2 | $565K | Buy |
4,495
+104
| +2% | +$14.1K | ﹤0.01% | 3885 |
|
|
2021
Q1 | $670K | Buy |
4,391
+1,506
| +52% | +$273K | ﹤0.01% | 3709 |
|
|
2020
Q4 | $384K | Hold |
2,885
| – | – | ﹤0.01% | 3679 |
|
|
2020
Q3 | $381K | Buy |
2,885
+1,827
| +173% | +$369K | ﹤0.01% | 3511 |
|
|
2020
Q2 | $225K | Buy |
1,058
+823
| +350% | +$118K | ﹤0.01% | 3631 |
|
|
2020
Q1 | $18K | Hold |
235
| – | – | ﹤0.01% | 4046 |
|
|
2019
Q4 | $20K | Hold |
235
| – | – | ﹤0.01% | 4159 |
|
|
2019
Q3 | $57K | Hold |
235
| – | – | ﹤0.01% | 4049 |
|
|
2019
Q2 | $78K | Hold |
235
| – | – | ﹤0.01% | 4010 |
|
|
2019
Q1 | $80K | Buy |
+235
| New | +$95.2K | ﹤0.01% | 3939 |
|
|
2018
Q3 | – | Sell |
-25
| Closed | -$44K | – | 4153 |
|
|
2018
Q2 | $44K | Buy |
25
+18
| +257% | +$36.4K | ﹤0.01% | 3988 |
|
|
2018
Q1 | $19K | Hold |
7
| – | – | ﹤0.01% | 4019 |
|
|
2017
Q4 | $46K | Hold |
7
| – | – | ﹤0.01% | 3931 |
|
|
2017
Q3 | $82K | Hold |
7
| – | – | ﹤0.01% | 3856 |
|
|
2017
Q2 | $92K | Buy |
7
+4
| +133% | +$56.5K | ﹤0.01% | 3862 |
|
|
2017
Q1 | $57K | Hold |
3
| – | – | ﹤0.01% | 3929 |
|
|
2016
Q4 | $21K | Hold |
3
| – | – | ﹤0.01% | 3999 |
|
|
2016
Q3 | $43K | Hold |
3
| – | – | ﹤0.01% | 3932 |
|
|
2016
Q2 | $54K | Hold |
3
| – | – | ﹤0.01% | 3913 |
|
|
2016
Q1 | $105 | Hold |
3
| – | – | ﹤0.01% | 3821 |
|
|
2015
Q4 | $112K | Hold |
3
| – | – | ﹤0.01% | 3856 |
|
|
2015
Q3 | $187K | Hold |
3
| – | – | ﹤0.01% | 3705 |
|
|
2015
Q2 | $208K | Buy |
3
+2
| +200% | +$154K | ﹤0.01% | 3575 |
|
|
2015
Q1 | $74K | Buy |
+1
| New | +$67.2K | ﹤0.01% | 3811 |
|
Geode Capital Management's BIOC Position: Q4 2023 in Review
Geode Capital Management sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 10,504 shares — an estimated $13.1K sold.
Geode Capital Management first reported a position in BIOC in Q1 2015 and held it in 32 quarters. The position peaked at $670K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.
- Geode Capital Management reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
- Geode Capital Management sold 10,504 Biocept, Inc. shares in Q4 2023, an estimated $13.1K.
- Geode Capital Management first reported a position in Biocept, Inc. in Q1 2015 and held it in 32 quarters.
- Geode Capital Management's Biocept, Inc. position peaked at $670K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.